Exploration of Current and New Technologies for Accuracy of Diagnosing OSA

NCT07485582 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2026-03-20

No results posted yet for this study

Summary

Resmed is the manufacturer of medical devices which screen, diagnose, treat and monitor people with sleeping and respiratory disorders, such as obstructive sleep apnea (OSA).

From time to time, for regulatory, quality, and marketing purposes, there may be a need to test the various products performance against PSG (gold standard technology), and other products.

The purpose of this study is:

1. Products performance against PSG
2. comparison against other products, and
3. Assessments of potential new technologies

Conditions

Interventions

DEVICE

Device A

A finger worn OSA home sleep test (HST) diagnostic device

DEVICE

Device B

A wrist worn OSA home sleep test (HST) diagnostic device

DEVICE

Device C

Ring: wellness device

DEVICE

Device D

Torso and limb worn patches

DEVICE

Device E

An eye mask

DIAGNOSTIC_TEST

Screener A

A mobile app screener

Sponsors & Collaborators

  • KlinEra Global Services

    collaborator INDUSTRY
  • ResMed

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2026-10-31
Completion
2026-10-31
FDA Device
Yes

Countries

  • Australia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07485582 on ClinicalTrials.gov